CJC-1295 without DAC 10 vails/box

here are two primary forms: CJC-1295 with DAC (Drug Affinity Complex) and CJC-1295 without DAC. The distinction between them isn’t just academic—it has real implications for half-life, effectiveness, and side effect profile.

In this article, we’ll dive deep into:

The structure and mechanism of CJC-1295

The critical differences between CJC-1295 with DAC and without DAC

Their respective half-lives and biological activity

The pros and cons of each form

Why we ultimately recommend CJC-1295 without DAC if you’re using it at all

And why our top preference is Tesamorelin, the only FDA-approved peptide for reducing visceral fat

What Is CJC-1295?

CJC-1295 is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It works by stimulating the anterior pituitary to produce more endogenous growth hormone (GH), which then stimulates insulin-like growth factor 1 (IGF-1) production in the liver. This cascade supports:

Lean muscle growth

Fat metabolism

Improved recovery

Better sleep

Skin repair

Enhanced cognitive function

In its base form, CJC-1295 mimics the natural 44-amino acid GHRH but is modified to resist enzymatic breakdown and increase stability. But adding a Drug Affinity Complex (DAC) further alters its properties—dramatically.

What Is DAC?

DAC stands for Drug Affinity Complex, a molecular structure added to a peptide to prolong its half-life. In the case of CJC-1295, DAC binds to albumin in the blood, preventing rapid breakdown and extending the time it remains active in the body.

This leads to less frequent dosing—but also introduces potential drawbacks, particularly when it comes to side effects and overexposure.

CJC-1295 Without DAC: How It Works

CJC-1295 without DAC is also referred to as Mod GRF (1-29). This form has a shorter half-life of about 30 minutes, meaning it mimics the body’s natural pulsatile release of GHRH.

Key Benefits:

More physiologic growth hormone pulses

Reduced risk of side effects

Often used in combination with GHRP peptides (like Ipamorelin or GHRP-2) for synergistic release

Flexible dosing (often 5 days/week)

Half-Life:

~30 minutes to 2 hours, depending on formulation and injection site

CJC-1295 With DAC: The Extended-Release Option

When CJC-1295 is formulated with DAC, its half-life extends up to 8 days, allowing for once-weekly dosing. While this seems convenient, the constant GH stimulation it causes is not physiologic.

Potential Problems:

GH secretion remains elevated for prolonged periods, which can lead to receptor downregulation

Side effects such as flushing, water retention, tingling, and lethargy are more common

Harder to titrate or reverse if side effects occur

Mimics a chronic GH elevation, which the body doesn’t naturally do

Half-Life:

~6–8 days due to DAC-albumin binding

Choosing between CJC-1295 with DAC and without DAC isn’t about which is “stronger.”

It’s about matching the peptide to your goal — fat loss, performance, recovery, or long-term use.

The Muscle, Performance & Body Composition Blueprint explains how growth hormone signaling works, why pulsing matters, and how to avoid choosing the wrong tool.

→ Get the Muscle, Performance & Body Composition Blueprint

Why We Don’t Recommend CJC-1295 With DAC

Here’s the honest truth: while CJC-1295 with DAC may offer convenient weekly injections, that benefit comes with a steep cost in terms of safety and flexibility.